TOKYO - A health ministry panel on Friday greenlit Pfizer Inc.'s coronavirus vaccine for use in Japan, with health minister Norihisa Tamura saying it could become the first to receive formal approval from the country as early as Sunday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
